Literature DB >> 1500097

Prekallikrein activation in human, bovine, and rabbit plasmas: presence of an inhibitor in bovine plasma.

K M Weerasinghe1.   

Abstract

Contact of human plasma with a negatively charged surface such as dextran sulfate activates prekallikrein to kallikrein, which releases the vasoactive peptide bradykinin from high-molecular-weight kininogen. The dextran sulfate-induced activation of prekallikrein at 0 degree C (assayed by its amidolytic activity on the chromogenic substate S-2302) could not be observed in either bovine or rabbit plasmas when compared to human plasma. Neither bovine nor rabbit plasma inhibited the amidolytic activity of contact-activated human plasma at 0 degrees C. The activation of prekallikrein in human plasma was significantly inhibited by the addition of bovine plasma but not by rabbit plasma. Bovine plasma (0.025 units, 1 unit = 1 ml of plasma) caused 68.8% inhibition of prekallikrein activation. Eighty percent of the inhibitory property of bovine plasma was present in the greater than 30,000-molecular-weight fraction. These results indicate the presence of an inhibitor(s) of prekallikrein activation in bovine plasma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500097     DOI: 10.1007/bf00918810

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

1.  The interrelationship of coagulation of plasma and release of peptides.

Authors:  J MARGOLIS
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

2.  Isolation and characterization of an inhibitor of factor XIIa from bovine plasma.

Authors:  R D Thornton; E P Kirby
Journal:  J Biol Chem       Date:  1987-09-15       Impact factor: 5.157

3.  The regulation of human factor XIIa by plasma proteinase inhibitors.

Authors:  R A Pixley; M Schapira; R W Colman
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

4.  Inhibition of contact activation by platelet factor 4.

Authors:  M F Scully; K Weerasinghe; V V Kakkar
Journal:  Thromb Res       Date:  1980-11-15       Impact factor: 3.944

5.  Human factor XII (Hageman factor).

Authors:  K Fujikawa; E W Davie
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Properties of sulfatides in factor-XII-dependent contact activation.

Authors:  G Tans; J H Griffin
Journal:  Blood       Date:  1982-01       Impact factor: 22.113

7.  Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease.

Authors:  H Saito; M C Poon; W Vicic; G H Goldsmith; J E Menitove
Journal:  J Lab Clin Med       Date:  1978-07

Review 8.  Molecular assembly in the contact phase of the Hageman factor system.

Authors:  C G Cochrane; J H Griffin
Journal:  Am J Med       Date:  1979-10       Impact factor: 4.965

9.  Inhibition of Hageman factor activation.

Authors:  H L Nossel; H Rubin; M Drillings; R Hsieh
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

10.  Interaction of bovine factor XIIa with an inhibitor from bovine plasma.

Authors:  R D Thornton; E P Kirby
Journal:  Biochim Biophys Acta       Date:  1988-01-12
View more
  1 in total

1.  Inhibition of prekallikrein activation in human plasma by components of bovine plasma.

Authors:  K M Weerasinghe; E P Kirby
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.